152 related articles for article (PubMed ID: 37078903)
1. In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant.
Zhang H; Zhang Y; Hu H; Yang W; Xia X; Lei L; Lin R; Li J; Li Y; Gao H
Small; 2023 Aug; 19(33):e2301041. PubMed ID: 37078903
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy.
Yang A; Bai Y; Dong X; Ma T; Zhu D; Mei L; Lv F
Acta Biomater; 2021 Oct; 133():257-267. PubMed ID: 34407475
[TBL] [Abstract][Full Text] [Related]
3.
Jin L; Yang D; Song Y; Li D; Xu W; Zhu Y; Xu CF; Lu Y; Yang X
ACS Nano; 2022 Sep; 16(9):15226-15236. PubMed ID: 36018240
[TBL] [Abstract][Full Text] [Related]
4. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
5. Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy.
Qian Y; Jin H; Qiao S; Dai Y; Huang C; Lu L; Luo Q; Zhang Z
Biomaterials; 2016 Aug; 98():171-83. PubMed ID: 27192420
[TBL] [Abstract][Full Text] [Related]
6. A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis.
Qin L; Cao J; Shao K; Tong F; Yang Z; Lei T; Wang Y; Hu C; Umeshappa CS; Gao H; Peppas NA
Sci Adv; 2020 Sep; 6(36):. PubMed ID: 32917616
[TBL] [Abstract][Full Text] [Related]
7. Hollow Aluminum Hydroxide Modified Silica Nanoadjuvants with Amplified Immunotherapy Effects through Immunogenic Cell Death Induction and Antigen Release.
Tan J; Ding B; Zheng P; Chen H; Ma P; Lin J
Small; 2022 Aug; 18(34):e2202462. PubMed ID: 35896867
[TBL] [Abstract][Full Text] [Related]
8. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
9. Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma.
Dai H; Huang Y; Guo J; Li L; Ke Y; Cen L; Meng F; Chen X; Liu B; Qian X
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52634-52642. PubMed ID: 36383430
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
11. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
12. Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.
Liu L; Wang Y; Miao L; Liu Q; Musetti S; Li J; Huang L
Mol Ther; 2018 Jan; 26(1):45-55. PubMed ID: 29258739
[TBL] [Abstract][Full Text] [Related]
13. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
14. In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy.
Yang W; Zhu G; Wang S; Yu G; Yang Z; Lin L; Zhou Z; Liu Y; Dai Y; Zhang F; Shen Z; Liu Y; He Z; Lau J; Niu G; Kiesewetter DO; Hu S; Chen X
ACS Nano; 2019 Mar; 13(3):3083-3094. PubMed ID: 30835435
[TBL] [Abstract][Full Text] [Related]
15. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
[TBL] [Abstract][Full Text] [Related]
16. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
17. An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells.
Wang P; Zhao P; Dong S; Xu T; He X; Chen M
Theranostics; 2018; 8(1):223-236. PubMed ID: 29290804
[No Abstract] [Full Text] [Related]
18. Polydopamine nanoparticles cross-linked hyaluronic acid photothermal hydrogel with cascading immunoinducible effects for in situ antitumor vaccination.
Fang Z; Yan Z; Li Z; Yan C; Jia S; Qiu X; Wang Q; Hou H; Wu Y; Du F; Gong A; Zhang M
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132177. PubMed ID: 38729484
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccine for the effective immunotherapy of breast cancer.
Ni J; Song J; Wang B; Hua H; Zhu H; Guo X; Xiong S; Zhao Y
Biomed Pharmacother; 2020 Jun; 126():110046. PubMed ID: 32145586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
